What is the recommended dose of Esomeprazole (generic name) in neonates?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Esomeprazole dosing for neonates is typically 0.5 mg/kg once daily, as this dose has been shown to be effective in reducing esophageal acid exposure and the number of acidic reflux events in neonates 1. For premature neonates and those under 1 month of age, this dose is generally recommended to start. The medication should be administered at least 1 hour before a feeding, preferably in the morning. For neonates who cannot swallow capsules, the contents can be mixed with a small amount of water and administered via an oral syringe or feeding tube. Some key points to consider when administering esomeprazole to neonates include:

  • Treatment duration should be limited to the shortest time necessary to control symptoms, typically 4-8 weeks, with reassessment of the need for continued therapy.
  • Esomeprazole works by inhibiting the proton pump in gastric parietal cells, reducing acid production in the stomach, making it effective for treating gastroesophageal reflux disease (GERD) and related conditions in neonates.
  • However, long-term use should be approached cautiously due to potential risks including increased susceptibility to infections, altered gut microbiome, and possible effects on nutrient absorption.
  • Regular monitoring for adverse effects and periodic attempts to discontinue therapy are recommended, as seen in studies such as 2 and 1. It's also important to note that the pharmacokinetics of esomeprazole in neonates may be different from those in older children and adults, and the dose may need to be adjusted accordingly, as suggested by studies like 3 and 4. Overall, the use of esomeprazole in neonates should be carefully considered and monitored to ensure the best possible outcomes for these patients.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.